Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids

Pratik Sinha(University of California, San Francisco), Max R. O’Donnell(Columbia University), Shelief Y. Robbins-Juarez(Columbia University), David Furfaro(Beth Israel Deaconess Medical Center), John H. Fountain, Matthew J. Cummings(NewYork–Presbyterian Hospital), Daniel Brodie(Johns Hopkins University), Jeremy R. Beitler(Columbia University), Natalie Yip(Columbia University), Matthew R. Baldwin(Columbia University), Kevin Delucchi(University of California, San Francisco), Manoj V. Maddali(Stanford University), Matthew A. Adan(Columbia University), Carolyn S. Calfee(University of California, San Francisco), Michael Murn(Pulmonary and Allergy Associates), Aakriti Gupta, Amanda Rosen, Mahesh V. Madhavan(NewYork–Presbyterian Hospital), Darryl Abrams(Columbia University), Kristin M. Burkart(Columbia University Irving Medical Center), Alison Thompson(Pulmonary and Allergy Associates), Alexander K. Lyashchenko(Columbia University Irving Medical Center), Tejus Satish(Columbia University), June He(Washington University in St. Louis), Cara Agerstrand(Pulmonary and Allergy Associates)
American Journal of Respiratory and Critical Care Medicine
September 20, 2021
Cited by 295


Related Papers